DiaSorin is an Italian Company, listed on the stock market in the FTSE Italia Mid Cap Index and a Global Leader in the field of biotechnologies, with a presence in over 60 countries through its direct...
DiaSorin is an Italian Company, listed on the stock market in the FTSE Italia Mid Cap Index and a Global Leader in the field of biotechnologies, with a presence in over 60 countries through its direct sales network and in over 80 countries through independent distributors. For over 40 years the Company has been developing, producing and commercializing worldwide reagent kits for the In Vitro Diagnostics market, in particular for the Immunodiagnostics and Molecular Diagnostics segments. The Group, headquartered in Italy - Saluggia (VC) - is comprised of 27 companies located in Europe, the United States, Central and South America, Asia and South Africa, with 1,654 employees, 129 of whom work exclusively on R&D projects. DiaSorin's products are specifically designed for hospital and private testing laboratories, with an offer embracing different clinical areas. The products menu is unique for its width and presence of specialty tests which identify DiaSorin as the in vitro "Specialist".
Public Symbol
DIA
Founded Year
1968
Organization Website
diasorin.com
Organization Languages
English, Italian
Organization Revenue
609000
Alexa Ranking
452888
Current Technologies
gmail
google apps
office 365
mailchimp spf
google maps
apache
drupal
new relic
google play
mobile friendly
google tag manager
shutterstock
wordpress org
itunes
google analytics
google font api
nginx
Job Functions
Engineering
Sales
Information Technology
Support
Marketing
Finance
Human Resources
Product Management
Business Development
Operations
Accounting
Legal
Media And Commmunication
Education
molecular diagnostic
healthcare
biotechnology
prenatal screening
blood tests
vitamin d
infectious diseases
gi stool testing
in vitro diagnostic
immunoassay
health care
health
wellness & fitness
hospital & health care
Jeff Kormos's Work History and Education
DiaSorin
Vice President, US National Accounts and Canada Commercial